News Data News Press Releases
13.84 -0.29(-2.02%)07/08/2024
Arcus Biosciences Inc (RCUS)

Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
HeadlineTime (ET)Source
Arcus Biosciences Announces New Employment Inducement Grants06/25 16:35businesswire.com
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers06/10 08:30businesswire.com
Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock?06/07 11:56zacks.com
Arcus Biosciences to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference06/06 16:05businesswire.com
ZT Systems Announces ACX200 Solutions Featuring NVIDIA GB200 Grace Blackwell Superchips for Next-Generation Accelerated Computing06/02 09:00businesswire.com
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer06/02 08:00businesswire.com
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers06/01 08:00businesswire.com